Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluvirin (2006-2007) in Adults and Elderly
NCT00342940Phase 2Withdrawn
- Sponsor
- Novartis
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A virus hemagglutinin antigen (A/Uruguay/716/2007 H3N2) in influenza, sponsored by Novartis. Planned start Oct 2006; status: withdrawn.
02
Drugs
Influenza A virus hemagglutinin antigen (A/Uruguay/716/2007 H3N2)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00342940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00342940.